Geskin LJ - Search Results

1

Highly Sensitive Virome Capture Sequencing Technique VirCapSeq-VERT Identifies Partial Noncoding Sequences but no Active Viral Infection in Cutaneous T-Cell Lymphoma.

Anderson ME, Nagy-Szakal D, Jain K, Patrone CC, Frattini MG, Lipkin WI, Geskin LJ. Anderson ME, et al. Among authors: geskin lj. J Invest Dermatol. 2018 Jul;138(7):1671-1673. doi: 10.1016/j.jid.2018.01.024. Epub 2018 Feb 7. J Invest Dermatol. 2018. PMID: 29427587 Free article. No abstract available.

2

Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma.

Geskin LJ, Akilov OE, Lin Y, Lokshin AE. Geskin LJ, et al. Exp Dermatol. 2014 Aug;23(8):598-600. doi: 10.1111/exd.12455. Epub 2014 Jul 16. Exp Dermatol. 2014. PMID: 24862743 Free PMC article.

3

Black cat in a dark room: the absence of a directly oncogenic virus does not eliminate the role of an infectious agent in cutaneous T-cell lymphoma pathogenesis.

Dulmage BO, Feng H, Mirvish E, Geskin L. Dulmage BO, et al. Br J Dermatol. 2015;172(5):1449-51. doi: 10.1111/bjd.13519. Epub 2015 Mar 8. Br J Dermatol. 2015. PMID: 25385510 Free PMC article. No abstract available.

4

Clinical Insights and Emerging Strategies in Managing Cutaneous T-Cell Lymphoma.

Patrone CC, Geskin LJ. Patrone CC, et al. Among authors: geskin lj. J Drugs Dermatol. 2017 May 1;16(5):405-412. J Drugs Dermatol. 2017. PMID: 29028854 Review.

5

Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma.

Geskin LJ, Damiano JJ, Patrone CC, Butterfield LH, Kirkwood JM, Falo LD. Geskin LJ, et al. Melanoma Res. 2018 Jun;28(3):211-221. doi: 10.1097/CMR.0000000000000441. Melanoma Res. 2018. PMID: 29543704 Free PMC article. Clinical Trial.

6

An Integrated Data Resource for Genomic Analysis of Cutaneous T-Cell Lymphoma.

Chang LW, Patrone CC, Yang W, Rabionet R, Gallardo F, Espinet B, Sharma MK, Girardi M, Tensen CP, Vermeer M, Geskin LJ. Chang LW, et al. Among authors: geskin lj. J Invest Dermatol. 2018 Dec;138(12):2681-2683. doi: 10.1016/j.jid.2018.06.176. Epub 2018 Jul 5. J Invest Dermatol. 2018. PMID: 29981755 Free article. No abstract available.

7

Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma.

Lopez AT, Bates S, Geskin L. Lopez AT, et al. Am J Clin Dermatol. 2018 Dec;19(6):805-819. doi: 10.1007/s40257-018-0380-7. Am J Clin Dermatol. 2018. PMID: 30173294 Review.

8

Ustekinumab-associated disseminated verrucae.

Anderson ME, Queen D, Vance SL, Geskin LJ. Anderson ME, et al. Among authors: geskin lj. JAAD Case Rep. 2018 Nov 10;4(10):1030-1033. doi: 10.1016/j.jdcr.2018.08.014. eCollection 2018 Nov. JAAD Case Rep. 2018. PMID: 30456278 Free PMC article. No abstract available.

9

Harnessing the synergistic potential of biologically targeted therapies in cutaneous T-cell lymphoma.

Patrone CC, Geskin LJ. Patrone CC, et al. Among authors: geskin lj. Oncotarget. 2019 Mar 8;10(20):1860-1861. doi: 10.18632/oncotarget.26751. eCollection 2019 Mar 8. Oncotarget. 2019. PMID: 30956764 Free PMC article. No abstract available.

10

Multifocal pleomorphic dermal sarcoma and the role of inflammation and immunosuppression in a lung transplant patient: a case report.

Anderson ME, Rodic N, Subtil A, Queen D, Arcasoy S, Niedt GW, Heald PW, Geskin LJ. Anderson ME, et al. Among authors: geskin lj. J Med Case Rep. 2019 May 30;13(1):169. doi: 10.1186/s13256-019-2093-9. J Med Case Rep. 2019. PMID: 31142349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters